... Outside the HLA region, interferon (IFN) pathway genes, which encode cytokines with critical modulatory effects on innate and adaptive immunity, have been shown to represent a key component of the genetic network leading ...
... Systemic lupuserythematosus (SLE), a complex polygenic autoimmune disease, is associated with increased complement activation. Variants of genes encoding complement regulator factor H (CFH) and five ...
... Systemic lupuserythematosus is a chronic autoimmune inflammatory disease characterized by a myriad of immunoregulatory abnormalities that lead to injuries of tissues and ...of lupus nephritis is ...
... The ubiquitin associated and Src-homology 3 (SH3) domain containing A (UBASH3a) is a suppressor of T-cell receptor signaling, underscoring antigen presentation to T-cells as a critical shared mechanism of diseases ...
... in LupusErythematosus National Assessment version of the Systemic LupusErythematosus Disease Activity Index (SLEDAI) [21] and the Systemic Lupus International Collaborating ...
... Systemic LupusErythematosus (SLE) is an autoimmune disease, characterized by autoantibodies generation and B lymphocyte activation, with a variety of clinical ...
... 8. Andersen LS, Petersen J, Svenson M, Bendtzen K: Production of IL- 1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity 1999, 30(4):235-242. 9. Lit LC, Wong CK, Tam LS, Li ...
... Systemic lupuserythematosus (SLE [OMIM 152700]) is a complex and heterogeneous autoimmune disease with a strong genetic component that is modified by environmental ...
... status. Lupus Nephritis (LN) is defined as clinical and laboratory manifestations that meet ACR criteria (persistent proteinuria and/ or cellular casts including red blood cells [RBCs], hemoglobin, granular, ...
... the Lupus Family Registry and Repository (86) at the Oklahoma Medical Research Foundation (OMRF), the Cincinnati Children’s Hospital Medical Center (CCHMC), the University of Texas SouthWestern (UTSW), the Center ...
... Funding: This work was supported by grants from the US National Institutes of Health (AR060366, AR053483, AR43814, AR049084, AR002138, AR030692, AR053308, AR057172, AI094377, AI101934, AI082714, AI063274, AI070304, ...
... attended the out-patient clinic of the University Hospital Virgen de las Nieves of Granada, Spain, were included (Table 1). Exclusion criteria were less than 1 year of follow-up in our unit. Current clinical assessment ...
... de lupus, se ha demostrado como la administración de análogos de la vitamina D reduce la severidad de la proteinuria, la formación de granulomas y mejora la arteritis renal y la alopecia ...del lupus como ...
... The relationship of anti-DNA antibody idiotypes and anticardiolipin antibodies to disease activity in systemic lupus erythematosus.. Weidmann CE, Wallace DJ, Peter JB, Knight PT, Bear M[r] ...
... Cutaneous lupuserythematosus includes a variety of lupuserythematosus-specific skin lesions that are subdivided into three categories: acute lupuserythematosus, subacute ...
... Systemic LupusErythematosus. Studies have shown that most lupus-related genes contain at least one miRNA target site for more than hundred ...in lupus T cells ...